{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:44Z","timestamp":1787023604673,"version":"build-2736575974"},"reference-count":94,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2018,9,13]]},"DOI":"10.18632\/aging.101551","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T14:52:40Z","timestamp":1536850360000},"page":"2367-2382","source":"Crossref","is-referenced-by-count":36,"title":["YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression"],"prefix":"10.18632","volume":"10","author":[{"given":"Pol","family":"Andr\u00e9s-Benito","sequence":"first","affiliation":[{"name":"Department of Pathology and Experimental Therapeutics, University of Barcelona, L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Bellvitge Biomedical Research Institute (IDIBELL), L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Colomina","sequence":"additional","affiliation":[{"name":"Anesthesia and Critical Care Department, Bellvitge University Hospital - University of Barcelona L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[{"name":"Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Bellvitge Biomedical Research Institute (IDIBELL), L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Povedano","sequence":"additional","affiliation":[{"name":"Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L\u2019Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Experimental Therapeutics, University of Barcelona, L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Bellvitge Biomedical Research Institute (IDIBELL), L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, IDIBELL, L\u2019Hospitalet de Llobregat, Barcelona, Spain"},{"name":"Institute of Neurosciences, University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.biotechadv.2013.09.012","article-title":"From bacteria to human: a journey into the world of chitinases.","volume":"3","author":"Faramarzi","year":"2013","journal-title":"Biotechnol Adv"},{"key":"2","first-page":"1025","article-title":"Production, purification and properties of fungal chitinases--a review.","volume":"5","author":"Pandey","year":"2014","journal-title":"Indian J Exp Biol"},{"key":"3","doi-asserted-by":"publisher","first-page":"791907","DOI":"10.1155\/2015\/791907","article-title":"Chitinases\u00a0from bacteria to human: properties, applications, and future perspectives.","volume":"201","author":"Gupta","year":"2015","journal-title":"Enzyme Res"},{"key":"4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.imbio.2015.11.014","article-title":"Chitinases and immunity: ancestral molecules with new functions.","volume":"22","author":"Malaguarnera","year":"2016","journal-title":"Immunobiology"},{"key":"5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00294-015-0530-x","article-title":"Fungal chitinases: function, regulation, and potential roles in plant\/pathogen interactions.","volume":"6","author":"G\u00f6hre","year":"2016","journal-title":"Curr Genet"},{"key":"6","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/onc.2009.292","article-title":"YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.","volume":"2","author":"Yan","year":"2009","journal-title":"Oncogene"},{"key":"7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury.","volume":"7","author":"Elias","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"8","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1158\/1078-0432.CCR-04-1765","article-title":"YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.","volume":"1","author":"Aldape","year":"2005","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","article-title":"YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.","volume":"17","author":"Wiley","year":"2008","journal-title":"Am J Pathol"},{"key":"10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases.","volume":"7","author":"Wiley","year":"2010","journal-title":"J Neuroinflammation"},{"key":"11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1089\/neu.2010.1310","article-title":"YKL-40 expression in traumatic brain injury: an initial analysis.","volume":"2","author":"Wagner","year":"2010","journal-title":"J Neurotrauma"},{"key":"12","first-page":"226","article-title":"YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.","volume":"3","author":"Wiley","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.","volume":"13","author":"Montalban","year":"2010","journal-title":"Brain"},{"key":"14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fonc.2014.00090","article-title":"Unveiling YKL\u201040, from serum marker to target therapy in glioblastoma.","volume":"4","author":"Hormigo","year":"2014","journal-title":"Front Oncol"},{"key":"15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jneuroim.2016.01.013","article-title":"YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.","volume":"29","author":"Malmestr\u00f6m","year":"2016","journal-title":"J Neuroimmunol"},{"key":"16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2016.08.004","article-title":"Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.","volume":"29","author":"Zetterberg","year":"2016","journal-title":"J Neuroimmunol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/ene.13687","article-title":"Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.","volume":"2","author":"Rami\u00f3-Torrent\u00e0","year":"2018","journal-title":"Eur J Neurol"},{"key":"18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease.","volume":"6","author":"D\u2019Angelo","year":"2010","journal-title":"Biol Psychiatry"},{"key":"19","doi-asserted-by":"publisher","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","article-title":"Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer\u2019s disease.","volume":"6","author":"Kaye","year":"2011","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1002\/mds.25589","article-title":"The glial marker YKL-40 is decreased in synucleinopathies.","volume":"2","author":"Zetterberg","year":"2013","journal-title":"Mov Disord"},{"key":"21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-2012-120787","article-title":"Microglial markers are elevated in the prodromal phase of Alzheimer\u2019s disease and vascular dementia.","volume":"3","author":"Hansson","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer\u2019s disease.","volume":"4","author":"Molinuevo","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1326-9-22","article-title":"Identification of longitudinally dynamic biomarkers in Alzheimer\u2019s disease cerebrospinal fluid by targeted proteomics.","volume":"9","author":"Honigberg","year":"2014","journal-title":"Mol Neurodegener"},{"key":"24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-140240","article-title":"Relationship between \u03b2-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer\u2019s disease.","volume":"4","author":"Lle\u00f3","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000362164","article-title":"Increased levels of chitotriosidase and YKL-40 in cerebrospinal fluid from patients with Alzheimer\u2019s disease.","volume":"4","author":"Zetterberg","year":"2014","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-015-0142-1","article-title":"Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer\u2019s disease in a memory clinic cohort.","volume":"7","author":"Fagan","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"27","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.neurobiolaging.2015.03.001","article-title":"Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer\u2019s disease.","volume":"3","author":"Carmona-Iragui","year":"2015","journal-title":"Neurobiol Aging"},{"key":"28","doi-asserted-by":"publisher","first-page":"e0135458","DOI":"10.1371\/journal.pone.0135458","article-title":"The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer\u2019s but not Parkinson\u2019s disease or dementia with Lewy bodies.","volume":"1","author":"Nielsen","year":"2015","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neurobiolaging.2015.10.022","article-title":"CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD.","volume":"3","author":"Molinuevo","year":"2016","journal-title":"Neurobiol Aging"},{"key":"30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/acn3.266","article-title":"Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer\u2019s disease.","volume":"3","author":"Hansson","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.dadm.2015.12.004","article-title":"Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.","volume":"2","author":"Pijnenburg","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"32","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jalz.2017.01.021","article-title":"Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer\u2019s disease.","volume":"1","author":"Floris","year":"2017","journal-title":"Alzheimers Dement"},{"key":"33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.","volume":"1","author":"Correia","year":"2017","journal-title":"Mol Neurodegener"},{"key":"34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","article-title":"CSF sAPP\u03b2, YKL-40, and neurofilament light in frontotemporal lobar degeneration.","volume":"8","author":"Pi\u00f1ol-Ripoll","year":"2017","journal-title":"Neurology"},{"key":"35","doi-asserted-by":"publisher","first-page":"e940","DOI":"10.4088\/JCP.16m11019","article-title":"Cognitive deficits in patients with neuropsychiatric symptoms: A comparative study between behavioral variant frontotemporal dementia and primary psychiatric disorders.","volume":"7","author":"Dols","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"36","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1089\/neu.2010.1310","article-title":"YKL-40 expression in traumatic brain injury: an initial analysis.","volume":"2","author":"Wagner","year":"2010","journal-title":"J Neurotrauma"},{"key":"37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation.","volume":"2","author":"Wiley","year":"2012","journal-title":"Brain Pathol"},{"key":"38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/neup.12158","article-title":"Role for mammalian chitinase 3-like protein 1 in traumatic brain injury.","volume":"3","author":"Kochanek","year":"2015","journal-title":"Neuropathology"},{"key":"39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12974-017-0893-7","article-title":"YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer\u2019s disease and other tauopathies.","volume":"1","author":"Lle\u00f3","year":"2017","journal-title":"J Neuroinflammation"},{"key":"40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/bpa.12538","article-title":"Diversity of astroglial responses across human neurodegenerative disorders and brain aging.","volume":"2","author":"Ferrer","year":"2017","journal-title":"Brain Pathol"},{"key":"41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jns.2014.12.016","article-title":"Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study.","volume":"34","author":"Mazzini","year":"2015","journal-title":"J Neurol Sci"},{"key":"42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/jnnp-2017-317138","article-title":"Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression.","volume":"8","author":"Giese","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.mcn.2017.10.001","article-title":"CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients.","volume":"8","author":"Di Rosa","year":"2017","journal-title":"Mol Cell Neurosci"},{"key":"44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.25143","article-title":"Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.","volume":"8","author":"Turner","year":"2018","journal-title":"Ann Neurol"},{"key":"45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","article-title":"CSF sAPP\u03b2, YKL-40, and NfL along the ALS-FTD spectrum.","volume":"8","author":"Clarim\u00f3n","year":"2017","journal-title":"Neurology"},{"key":"46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1022476724381","article-title":"Increases in fragmented glial fibrillary acidic protein levels in the spinal cords of patients with amyotrophic lateral sclerosis.","volume":"2","author":"Nagata","year":"1998","journal-title":"Neurochem Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14660820410020286","article-title":"Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells.","volume":"5","author":"Vinters","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ana.10805","article-title":"Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue.","volume":"5","author":"Appel","year":"2004","journal-title":"Ann Neurol"},{"key":"49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/187152710791292657","article-title":"Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity?","volume":"9","author":"Chi\u00f2","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","article-title":"Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue.","volume":"17","author":"Aronica","year":"2011","journal-title":"Neuroscience"},{"key":"51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.","volume":"4","author":"Baas","year":"2011","journal-title":"Neurobiol Dis"},{"key":"52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/156652411795243450","article-title":"The Role of immune and inflammatory mechanisms in ALS.","volume":"1","author":"Henderson","year":"2011","journal-title":"Curr Mol Med"},{"key":"53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.","volume":"1","author":"Robberecht","year":"2011","journal-title":"Lancet Neurol"},{"key":"54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mcn.2012.10.008","article-title":"Inflammation and neurovascular changes in amyotrophic lateral sclerosis.","volume":"5","author":"Turner","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","article-title":"Protective and toxic neuroinflammation in amyotrophic lateral sclerosis.","volume":"1","author":"Appel","year":"2015","journal-title":"Neurotherapeutics"},{"key":"56","first-page":"537","article-title":"Neuroinflammation in motor neuron disease.","volume":"7","author":"Yamanaka","year":"2015","journal-title":"Nagoya J Med Sci"},{"key":"57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bpa.12352","article-title":"Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers.","volume":"2","author":"Amor","year":"2016","journal-title":"Brain Pathol"},{"key":"58","doi-asserted-by":"publisher","first-page":"823","DOI":"10.18632\/aging.101195","article-title":"Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration.","volume":"9","author":"Ferrer","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"59","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications.","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"key":"60","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0022-510X(97)00228-1","article-title":"Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases.","volume":"15","author":"Niland","year":"1998","journal-title":"J Neurol Sci"},{"key":"61","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17482960701419232","article-title":"RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.","volume":"8","author":"Vassilopoulos","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"key":"62","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","article-title":"Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.","volume":"1","author":"Czaplinski","year":"2009","journal-title":"Eur J Neurol"},{"key":"63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.","volume":"7","author":"Connor","year":"2009","journal-title":"Neurology"},{"key":"64","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000287582","article-title":"Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.","volume":"6","author":"Evdokimidis","year":"2010","journal-title":"Eur Neurol"},{"key":"65","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0404.2010.01333.x","article-title":"Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation?","volume":"12","author":"Evdokimidis","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"66","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-7-76","article-title":"IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients.","volume":"7","author":"Tong","year":"2010","journal-title":"J Neuroinflammation"},{"key":"67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2010.03.004","article-title":"CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis.","volume":"22","author":"Kira","year":"2010","journal-title":"J Neuroimmunol"},{"key":"68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1742-2094-11-94","article-title":"Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis.","volume":"1","author":"Boraschi","year":"2014","journal-title":"J Neuroinflammation"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2017.07.020","article-title":"Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1\u03b2 (MIP-1\u03b2) in patients with amyotrophic lateral sclerosis.","author":"Garc\u00eda Sarre\u00f3n","year":"2017","journal-title":"Neurologia"},{"key":"70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/17482960802651725","article-title":"CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients.","volume":"1","author":"Devos","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"71","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jneuroim.2004.10.009","article-title":"Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).","volume":"15","author":"McGrath","year":"2005","journal-title":"J Neuroimmunol"},{"key":"72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jneuroim.2006.10.001","article-title":"Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate.","volume":"18","author":"Kira","year":"2007","journal-title":"J Neuroimmunol"},{"key":"73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2007.10.028","article-title":"TNF and sTNFR1\/2 plasma levels in ALS patients.","volume":"19","author":"Ceroni","year":"2008","journal-title":"J Neuroimmunol"},{"key":"74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","article-title":"Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process.","volume":"21","author":"Mora","year":"2009","journal-title":"J Neuroimmunol"},{"key":"75","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-0404.2011.01528.x","article-title":"Alterations of T cell subsets in ALS: a systemic immune activation?","volume":"12","author":"Evdokimidis","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"76","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-0404.2011.01528.x","article-title":"Alterations of T cell subsets in ALS: a systemic immune activation?","volume":"12","author":"Evdokimidis","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.","volume":"5","author":"Appel","year":"2013","journal-title":"EMBO Mol Med"},{"key":"78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","article-title":"Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes.","volume":"7","author":"Appel","year":"2017","journal-title":"JAMA Neurol"},{"key":"79","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrneurol.2017.149","article-title":"Motor neuron disease: peripheral immune cell levels correlate with disease progression in ALS.","volume":"1","author":"Sidaway","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"80","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fneur.2017.00546","article-title":"Inflammatory Gene expression in whole peripheral blood at early stages of sporadic amyotrophic lateral sclerosis.","volume":"8","author":"Ferrer","year":"2017","journal-title":"Front Neurol"},{"key":"81","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.","volume":"7","author":"Otto","year":"2016","journal-title":"Ann Neurol"},{"key":"82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jnnp-2015-311387","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients.","volume":"8","author":"Muche","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"83","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.","volume":"1","author":"Herukka","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"84","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","article-title":"Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.","volume":"9","author":"Amador","year":"2018","journal-title":"Neurology"},{"key":"85","doi-asserted-by":"publisher","first-page":"e0164625","DOI":"10.1371\/journal.pone.0164625","article-title":"Neurofilaments\u00a0as biomarkers for amyotrophic lateral sclerosis: A systematic review and meta-analysis.","volume":"1","author":"McCombe","year":"2016","journal-title":"PLoS One"},{"key":"86","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","article-title":"CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.","volume":"26","author":"La Bella","year":"2018","journal-title":"J Neurol"},{"key":"87","doi-asserted-by":"crossref","unstructured":"Ferrer I. Brain Banking. In: Aminoff MJ, Daroff RB (eds.) Encyclopedia of the Neurological Sciences, 2nd edition. Oxford: Academic Press 2014; 1, pp. 467-473.","DOI":"10.1016\/B978-0-12-385157-4.00585-6"},{"key":"88","unstructured":"Ince PG, Highley JR, Wharton SB. Motor neuron disorders. In: Love S, Budka H, Ironside JW, Perry A (eds.). Greenfield\u2019s Neuropathology, Ninth edition. Boca Raton: CRC Press, Taylor and Francis Group. 2015, pp. 817-848."},{"key":"89","doi-asserted-by":"crossref","unstructured":"Strong MJ, Hortob\u00e1gyi T, Okamoto K, Kato S. Amyotrophic lateral sclerosis, primary lateral sclerosis, and spinal muscular atrophy. In: Dickson DW, Weller R.O (eds.) Neurodegeneration: the molecular pathology of dementia and movement disorders. 2\n                      nd\n                      edition. Oxford: Wiley-Blackwell. 2011, pp. 418-433.","DOI":"10.1002\/9781444341256.ch44"},{"key":"90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuint.2006.01.018","article-title":"TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue.","volume":"4","author":"Ferrer","year":"2006","journal-title":"Neurochem Int"},{"key":"91","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00401-012-1027-z","article-title":"Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study.","volume":"12","author":"Palkovits","year":"2012","journal-title":"Acta Neuropathol"},{"key":"92","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mad.2009.12.005","article-title":"Validation of suitable internal control genes for expression studies in aging.","volume":"13","author":"Caiafa","year":"2010","journal-title":"Mech Ageing Dev"},{"key":"93","doi-asserted-by":"publisher","first-page":"e87508","DOI":"10.1371\/journal.pone.0087508","article-title":"Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis.","volume":"9","author":"Shaw","year":"2014","journal-title":"PLoS One"},{"key":"94","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests.","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T14:12:29Z","timestamp":1599055949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":94,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,30]]}},"alternative-id":["101551","30215603"],"URL":"https:\/\/doi.org\/10.18632\/aging.101551","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]}}}